Steering the FDA back to a place of regulatory steadiness and certainty won’t be easy, Bloomberg Opinion columnist Lisa Jarvis writes.

In an ideal world, this week’s resignation of Food and Drug Administration Commissioner Marty Makary would signal the end of a troubling period at the agency — one where the job of overseeing a ...

Dr. Tracy Beth Høeg is leaving her role as head of the FDA division that regulates over-the-counter and prescription drugs, ...

Commissioner Marty Makary in trying to reduce the list of routine shots recommended for all babies and children.

FDA staffers are buzzing about who in former FDA Commissioner Marty Makary’s orbit will be next to leave the agency.

The acting head of the U.S. Food and Drug Administration’s drug center, Tracey Beth Hoeg, is expected to leave the agency ...

With the ink barely dry on outgoing commissioner Marty Makary’s resignation, another top regulator may be heading for the exit at the FDA.  | With the ink barely dry on outgoing commissioner Marty ...

As Donald Trump leaves Beijing after meeting Xi Jinping, how much did this diplomacy accomplish? Plus, does Dr. Marty Makary's resignation at the FDA signal an agency turn? And the High Court halts an ...

A third of patients in a clinical trial had tumors shrink while taking a genetically engineered treatment known as RP1.

The Trump administration’s moves to make flavored vapes more widely available have caused a splintering among some in the ...

Several key allies of former Food and Drug Administration commissioner Marty Makary are departing the agency, according to ...